Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2074
  • 2075
  • 2076
  • …
  • ›
  • »

2026-04-15

CareRx Corporation: CareRx Corporation Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference

2026-04-15

Leidos Holdings, Altaris To Form Joint Venture To Provide Advanced Security Screening Technologies

2026-04-15

Investment Grade BDC Offers High Yield Despite Rate Headwinds

2026-04-15

PNC Profit Rises on Robust Client Activity

2026-04-15

EQS-News: Aryza Acquires Umbrella Tech, advancing Collection Intelligence with voice-based Agentic AI for the global Collections & Recoveries industry

2026-04-15

Taso Tsakos Joins Golden Gate Sotheby′s International Realty

2026-04-15

GXO Logistics extends French logistics partnership with Electro Dépôt

2026-04-15

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

2026-04-15

Taboola lays off 5% of workforce

2026-04-15

PNC Profit Rises on Robust Client Activity

2026-04-15

hVIVO: beating the odds in 2025 - and why 2026 looks better still

2026-04-15

Terremoto Biosciences Closes $108 Million Series C Financing to Advance Selective AKT1-Inhibitors in Oncology and Hereditary Hemorrhagic Telangiectasia

  • «
  • ‹
  • …
  • 2074
  • 2075
  • 2076
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies